The increase in FGF23 in those patients led to an early development of secondary hypertension by suppression of 1,25(OH)2D production (17), and low phosphate intake of phosphorus binders caused 35% decrease in plasma FGF23 level (18). This evidence concerns the gene FGF23 and secondary hypertension.